Literature DB >> 12582407

Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy.

Lotus Mallbris1, Anders Ljungberg, Mari-Anne Hedblad, Per Larsson, Mona Ståhle-Bäckdahl.   

Abstract

We describe a patient with widespread and progressive cutaneous sarcoidosis who was successfully treated with anti-tumor necrosis factor-alpha monoclonal antibody, infliximab, suggesting that inhibition of tumor necrosis factor-alpha may be useful as targeted treatment in cutaneous sarcoidosis.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12582407     DOI： 10.1067/mjd.2003.228

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  11 in total

1.  [Successful topical treatment of cutaneous sarcoidosis with tacrolimus].

Authors:  R Gutzmer; B Völker; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2003-12       Impact factor: 0.751

2.  Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis.

Authors:  K Vandevyvere; F P Luyten; P Verschueren; R Lories; S Segaert; R Westhovens
Journal:  Clin Rheumatol       Date:  2007-09-18       Impact factor: 2.980

3.  Infliximab therapy for hepatic and intestinal sarcoidosis.

Authors:  Helen S Te; Lucas Campbell; Saima Chohan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-06

4.  Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case report.

Authors:  Supen R Patel
Journal:  J Med Case Rep       Date:  2009-07-29

5.  Psoriasiform Sarcoidosis: Collision of Two Entities or Expression of One Common Pathogenesis?

Authors:  Miriam L Vega; Jennifer Abrahams; Matthew Keller
Journal:  J Clin Aesthet Dermatol       Date:  2016-04-01

6.  Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis.

Authors:  S K Metyas; R M Tadros; D G Arkfeld
Journal:  Rheumatol Int       Date:  2008-09-02       Impact factor: 2.631

Review 7.  Evidence-based therapy for cutaneous sarcoidosis.

Authors:  Christy B Doherty; Ted Rosen
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 8.  Adaptive immune responses in primary cutaneous sarcoidosis.

Authors:  Matteo Bordignon; Paola Rottoli; Carlo Agostini; Mauro Alaibac
Journal:  Clin Dev Immunol       Date:  2011-03-30

9.  In vivo evaluation of TNF-alpha in the lungs of patients affected by sarcoidosis.

Authors:  Filippo Galli; Tiziana Lanzolla; Vittorio Pietrangeli; Gaurav Malviya; Alberto Ricci; Pierdonato Bruno; Paola Ragni; Francesco Scopinaro; Salvatore Mariotta; Alberto Signore
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

10.  Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis.

Authors:  José Luis Callejas-Rubio; Lourdes López-Pérez; Norberto Ortego-Centeno
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.